Unity Biotechnology, Inc.UBXNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+2.7%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+2.7%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 46.02% |
| 2023 | 24.26% |
| 2022 | -13.25% |
| 2021 | 42.48% |
| 2020 | -8.16% |
| 2019 | -27.90% |
| 2018 | -47.62% |
| 2017 | -133.92% |
| 2016 | 0.00% |